NCT04447482 is a NA clinical trial of ENB with image-guided lung biopsy in Lung Neoplasms, sponsored by Shanghai Youhe Medical Technology Co., Ltd..

Who is sponsoring NCT04447482?

NCT04447482 is sponsored by Shanghai Youhe Medical Technology Co., Ltd..

What drugs are being tested in NCT04447482?

Interventions in NCT04447482: ENB with image-guided lung biopsy, Conventional Bronchoscopy guided by Fluoroscopy.

What condition does NCT04447482 study?

NCT04447482 studies Lung Neoplasms, Pulmonary Neoplasm.

Is NCT04447482 still recruiting?

NCT04447482 is currently status unknown. Last updated 18 March 2021.

Last reviewed 2021-03-18 · How we verify

NCT04447482

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ENB Vs. Conventional Bronchoscopy With Fluoroscopy for Safe and Effective Biopsy of Pulmonary Lesions

Status unknown NA Last updated 18 March 2021

What this trial tests

NA trial testing ENB with image-guided lung biopsy in Lung Neoplasms in 212 participants. Status unknown.

Timeline

10 July 2020

Primary endpoint
30 June 2021

30 September 2021

Quick facts

Lead sponsor	Shanghai Youhe Medical Technology Co., Ltd.
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	212
Start date	10 July 2020
Primary completion	30 June 2021
Estimated completion	30 September 2021
Sites	4 locations across China

Drugs / interventions tested

ENB with image-guided lung biopsy
Conventional Bronchoscopy guided by Fluoroscopy

Conditions studied

Lung Neoplasms — all drugs for Lung Neoplasms →
Pulmonary Neoplasm — all drugs for Pulmonary Neoplasm →

Sponsor

Shanghai Youhe Medical Technology Co., Ltd.

Who can join

Adults 18 to 75, any sex, with Lung Neoplasms or Pulmonary Neoplasm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate results for participants with lung lesions randomized to either 4D Electromagnetic Navigation Bronchoscopy (4D-ENB) versus Conventional Bronchoscopy with Fluoroscopy for diagnostic biopsy and detection of lung cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lung Neoplasms

Currently open trials in the same condition.

NCT07476287 — Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult · Phase 2 · recruiting
NCT07509333 — MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients · NA · recruiting
NCT07109154 — DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First- · recruiting
NCT06974604 — Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM · Phase 2 · recruiting
NCT07165691 — TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04447482 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shanghai Youhe Medical Technology Co., Ltd.
Last refreshed: 18 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04447482.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing